Neurocognitive testing evaluates cognitive deficits commonly associated with addiction, such as impaired memory, attention, and executive functioning. Substance use often damages brain regions like the prefrontal cortex and hippocampus, leading to difficulties in decision-making, impulse control, and learning. Standardized tests, such as the Wisconsin Card Sorting Test and Stroop Test, help identify these impairments and guide personalized treatment plans. Neurocognitive assessments also aid in tracking recovery progress and predicting relapse risk. Integrating these evaluations into addiction care provides a comprehensive understanding of how substance use impacts brain function and highlights areas requiring cognitive rehabilitation.
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : Evaluation of prevalence and pattern of tobacco use in yenagoa city in bayelsa state south of nigeria
Owonaro Peter, Bayelsa State Drug Avuse Addiction Prevention and Rehabilitation Committee (BADAPARC), Nigeria
Title : Engaging learners through gamification, creativity, and human-centered design
Tero Moliis, Versantium, United States
Title : Neuropharmacological and regulatory drivers of tianeptine misuse in the united states: A growing public health concern
Darcy Tocci, NSU College of Pharmacy, United States
Title : Awakening sovereignty within: Healing trauma, releasing codependency, and returning to self-trust
Whitney Walker, Mental Health Therapist/ Podcast Host, United States
Title : You can save a life: Real conversations, real solutions for suicide prevention
frank King, The Mental Health Comedian, LLC, United States